InMed Pharmaceuticals Inc.
INM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728328
In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding InMed Pharmaceuticals Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 17 | 18 | +1 |
| Shares | 804.3K | 685.9K | −118.4K (−14.7%) |
| Value | $334.4K | $249.2K | −$85.2K (−25.5%) |
New holders (3)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BFSG, LLC | 200 | $73 | 0.00% |
| AdvisorNet Financial, Inc | 80 | $29 | 0.00% |
| UBS Group AG | 41 | $15 | 0.00% |
Sold out (2)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| TD Waterhouse Canada Inc. | 85 | $43 |
| Advisory Services Network, LLC | 59 | $25 |